overactive%20bladder
OVERACTIVE BLADDER

Overactive bladder or non-neurogenic overactive bladder is a syndrome characterized by urinary urgency, frequency, nocturia and urgency incontinence.
It is not a disease but a symptom complex that generally is not a life-threatening condition. It is also known as bladder spasms.
Urgency is the complaint of sudden, compelling desire to pass urine that is difficult to deny. It is considered a hallmark symptom of overactive bladder.
Frequency is usually micturition of >7 episodes during waking hours.
Nocturia is the interruption of sleep one or more times because of the need to void.
Urgency incontinence is the involuntary leakage of urine associated with a sudden compelling desire to void.

Overactive Bladder Drug Information

Drug Information

Indication: Symptomatic treatment of urgency, increased micturition frequency &/or urgency incontinence as may occur i...

Indication: Overactive bladder w/ symptoms of urge, urinary incontinence, urgency & frequency.

Indication: Symptomatic treatment of urge incontinence &/or increased urinary frequency & urgency.

Indication: Symptomatic treatment of urge incontinence &/or increased urinary frequency & urgency in patients w/ o...

Botox
clostridium botulinum toxin type A

Indication: Blepharospasm associated w/ dystonia including benign essential blepharospasm, hemifacial spasm, VIIth nerve d...

Indication: Overactive bladder w/ symptoms of urinary urgency, frequency or urge incontinence.

Dysport
botulinum A toxin

Indication: Symptomatic treatment of focal spasticity of upper limbs in adults & dynamic equinus foot deformity in amb...

Toviaz
fesoterodine fumarate

Indication: Overactive bladder w/ symptoms of urge urinary incontinence, urgency & frequency.

Editor's Recommendations
Most Read Articles
4 days ago
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Roshini Claire Anthony, 5 days ago

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

5 days ago
Regardless of treatment, serum hepcidin is elevated in patients with restless leg syndrome (RLS) and may act as a biomarker for this condition, a recent study has found.
Jairia Dela Cruz, Yesterday
In the first year following percutaneous coronary intervention for acute coronary syndrome, ticagrelor and prasugrel cuts the risk of gastrointestinal (GI) bleeding by more than 30 percent compared with clopidogrel, as shown in a large real-world study.